Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

DMAB-anabaseine dihydrochloride (CAS 32013-69-7)

0.0(0)
Write a reviewAsk a question

Alternate Names:
4-[(5,6-Dihydro[2,3′-bipyridin]-3(4H)-ylidene)methyl]-N,N-dimethylbenzenamine dihydrochloride
Application:
DMAB-anabaseine dihydrochloride is a neuronal AChR partial agonist
CAS Number:
32013-69-7
Molecular Weight:
364.32
Molecular Formula:
C19H21N32HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

DMAB-anabaseine dihydrochloride is a compound that functions as a potent and selective agonist at the α7 nicotinic acetylcholine receptor. It acts by binding to the receptor and activating it, leading to the opening of ion channels and the influx of calcium ions into the cell. This activation of the α7 nicotinic acetylcholine receptor may modulate neurotransmitter release, particularly enhancing the release of dopamine, glutamate, and GABA. In experimental applications, DMAB-anabaseine dihydrochloride is used to study the role of the α7 nicotinic acetylcholine receptor in various physiological and pathological processes. Its mechanism of action at the molecular level involves specific interactions with the receptor protein, leading to downstream signaling cascades and cellular responses. DMAB-anabaseine dihydrochloride serves as a useful tool for investigating the function and pharmacology of the α7 nicotinic acetylcholine receptor in diverse experimental applications.


DMAB-anabaseine dihydrochloride (CAS 32013-69-7) References

  1. Characterization of [(3)H]CHIBA-1001 binding to alpha7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human.  |  Tanibuchi, Y., et al. 2010. Brain Res. 1348: 200-8. PMID: 20537987
  2. Pharmacological characterization of [(125)I]CHIBA-1006 binding, a new radioligand for α7 nicotinic acetylcholine receptors, to rat brain membranes.  |  Wu, J., et al. 2010. Brain Res. 1360: 130-7. PMID: 20816767
  3. Signals of vagal circuits engaging with AKT1 in α7 nAChR+CD11b+ cells lessen E. coli and LPS-induced acute inflammatory injury.  |  Zhao, C., et al. 2017. Cell Discov. 3: 17009. PMID: 28529765

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

DMAB-anabaseine dihydrochloride, 1 mg

sc-203568
1 mg
$377.00